Open Market Insiders Trades
This list includes insiders general transaction with codes filed in Form 4 from SEC:
- P - Open market or private purchase of non-derivative or derivative security
- S - Open market or private sale of non-derivative or derivative security
- V - Transaction voluntarily reported earlier than required
| Ticker | Insider | Transaction Type | Ownership Type | Shares Traded | Value / Price | Filing Date |
|---|---|---|---|---|---|---|
|
HWM
|
Neil Edward Marchuk
EVP, HR |
SELL
Open market or private sale
|
Direct | 30,000 Reduced 18.53% |
$4,755,900
$158.53 p/Share
|
May 12
2025 |
|
ENR
|
Patrick J Moore
Director |
BUY
Open market or private purchase
|
Indirect | 10,000 Added 0.0% |
$231,000
$23.1 p/Share
|
May 12
2025 |
|
PGY
|
Avital Pardo
Chief Technology Officer |
SELL
Open market or private sale
|
Direct | 121,289 Reduced 4.59% |
$1,838,741
$15.16 p/Share
|
May 12
2025 |
|
PGY
|
Avital Pardo
Chief Technology Officer |
SELL
Open market or private sale
|
Direct | 116,459 Reduced 100.0% |
$1,765,518
$15.16 p/Share
|
May 12
2025 |
|
GL
|
Rebecca E Zorn
EVP & Chief Talent Officer |
SELL
Open market or private sale
|
Direct | 10,000 Reduced 42.29% |
$1,217,000
$121.7 p/Share
|
May 12
2025 |
|
PGY
|
Yahav Yulzari
Chief Business Officer |
SELL
Open market or private sale
|
Direct | 238,004 Reduced 5.19% |
$3,608,140
$15.16 p/Share
|
May 12
2025 |
|
FOR
|
Elizabeth Parmer
Director |
SELL
Open market or private sale
|
Direct | 1,460 Reduced 30.31% |
$30,032
$20.57 p/Share
|
May 12
2025 |
|
MVBF
|
Joseph Ryan Rodriguez
Chief Risk Officer |
BUY
Open market or private purchase
|
Direct | 1,125 Added 17.65% |
$21,543
$19.15 p/Share
|
May 12
2025 |
|
AXON
|
Julie A Cullivan
Director |
SELL
Open market or private sale
|
Direct | 657 Reduced 27.47% |
$459,900
$700.0 p/Share
|
May 12
2025 |
|
TEAM
|
Scott Farquhar |
SELL
Open market or private sale
|
Indirect | 7,948 Reduced 0.0% |
$1,759,766
$221.41 p/Share
|
May 12
2025 |
|
TEAM
|
Michael Cannon Brookes
CEO, Co-Founder |
SELL
Open market or private sale
|
Indirect | 7,948 Reduced 0.0% |
$1,759,766
$221.41 p/Share
|
May 12
2025 |
|
AXON
|
Joshua Isner
PRESIDENT |
SELL
Open market or private sale
|
Direct | 9,000 Reduced 2.83% |
$6,143,850
$682.65 p/Share
|
May 12
2025 |
|
BVFL
|
Joseph S Galli
Director |
SELL
Open market or private sale
|
Indirect | 3,454 Reduced 0.0% |
$54,987
$15.92 p/Share
|
May 12
2025 |
|
AXON
|
Jeri Williams
Director |
SELL
Open market or private sale
|
Direct | 657 Reduced 40.38% |
$459,900
$700.0 p/Share
|
May 12
2025 |
|
LIFX
|
Susan L. Stick
General Counsel |
SELL
Open market or private sale
|
Direct | 500 Reduced 0.45% |
$23,445
$46.89 p/Share
|
May 12
2025 |
|
MRVL
|
Chris Koopmans
President and COO |
SELL
Open market or private sale
|
Indirect | 6,000 Reduced 0.0% |
$390,000
$65.0 p/Share
|
May 12
2025 |
|
LYV
|
James S Kahan
Director |
SELL
Open market or private sale
|
Indirect | 3,410 Reduced 0.0% |
$475,763
$139.52 p/Share
|
May 12
2025 |
|
PCYG
|
Randall K Fields
CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Indirect | 5,000 Reduced 0.0% |
$111,649
$22.33 p/Share
|
May 12
2025 |
|
NTRS
|
Kelley Conway
Executive Vice President |
SELL
Open market or private sale
|
Direct | 500 Reduced 3.93% |
$52,640
$105.28 p/Share
|
May 12
2025 |
|
MORN
|
Joseph D Mansueto
Executive Chairman |
SELL
Open market or private sale
|
Direct | 7,250 Reduced 0.08% |
$2,242,787
$309.35 p/Share
|
May 12
2025 |
|
NTRS
|
David W Fox Jr
EVP & Chief Financial Officer |
SELL
Open market or private sale
|
Direct | 5,076 Reduced 26.61% |
$535,771
$105.55 p/Share
|
May 12
2025 |
|
GNLX
|
Ralph Smalling
Head of Regulatory |
SELL
Open market or private sale
|
Direct | 1,259 Reduced 3.5% |
$3,676
$2.92 p/Share
|
May 12
2025 |
|
GNLX
|
Joseph Cappello
VP, Pharmaceutical Development |
SELL
Open market or private sale
|
Direct | 4,737 Reduced 8.31% |
$13,832
$2.92 p/Share
|
May 12
2025 |
|
GNLX
|
Tony Yu
VP, Clinical Trial Operations |
SELL
Open market or private sale
|
Direct | 5,579 Reduced 10.48% |
$16,290
$2.92 p/Share
|
May 12
2025 |
|
GNLX
|
Thomas Zindrick
President and CEO |
SELL
Open market or private sale
|
Direct | 10,764 Reduced 5.32% |
$31,430
$2.92 p/Share
|
May 12
2025 |
|
GNLX
|
Sean Ryder
General Counsel |
SELL
Open market or private sale
|
Direct | 4,475 Reduced 8.59% |
$13,067
$2.92 p/Share
|
May 12
2025 |
|
HIMS
|
Soleil Boughton
Chief Legal Officer |
SELL
Open market or private sale
|
Direct | 3,235 Reduced 2.03% |
$181,160
$56.0 p/Share
|
May 12
2025 |
|
HIMS
|
Melissa Baird
Chief Operating Officer |
SELL
Open market or private sale
|
Direct | 33,333 Reduced 3.98% |
$1,879,314
$56.38 p/Share
|
May 12
2025 |
|
MORN
|
Michael Holt
Chief Financial Officer |
SELL
Open market or private sale
|
Direct | 353 Reduced 7.16% |
$109,080
$309.01 p/Share
|
May 12
2025 |
|
CHAR
|
Kah Wei Tan
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 1,905,000 Reduced 0.0% |
$3,524,250
$1.85 p/Share
|
May 12
2025 |
|
CHAR
|
Kah Wei Tan
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 255,000 Reduced 0.0% |
$471,750
$1.85 p/Share
|
May 12
2025 |
|
PFGC
|
Hugh Patrick Hatcher |
SELL
Open market or private sale
|
Direct | 3,000 Reduced 7.49% |
$261,660
$87.22 p/Share
|
May 12
2025 |
|
DRTT
|
Scott L Robinson |
BUY
Open market or private purchase
|
Direct | 10,000 Added 3.41% |
$6,100
$0.61 p/Share
|
May 12
2025 |
|
FLWS
|
Fund 1 Investments, LLC
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 75,000 Added 0.0% |
$376,499
$5.02 p/Share
|
May 12
2025 |
|
EML
|
Frederick D. Di Santo
Director |
BUY
Open market or private purchase
|
Direct | 1,000 Added 1.39% |
$23,500
$23.5 p/Share
|
May 12
2025 |
|
AESI
|
Ben M Brigham
Executive Chairman |
BUY
Open market or private purchase
|
Direct | 20,400 Added 3.55% |
$271,728
$13.32 p/Share
|
May 12
2025 |
|
AZZ
|
Thomas E Ferguson
President and CEO |
SELL
Open market or private sale
|
Direct | 4,973 Reduced 2.32% |
$467,014
$93.91 p/Share
|
May 12
2025 |
|
EXPD
|
Daniel R Wall
President and CEO |
SELL
Open market or private sale
|
Direct | 9,996 Reduced 14.21% |
$1,158,636
$115.91 p/Share
|
May 12
2025 |
|
MGPI
|
Caroline Lux Kaplan |
SELL
Open market or private sale
|
Indirect | 32,500 Reduced 0.0% |
$1,085,825
$33.41 p/Share
|
May 12
2025 |
|
DT
|
Dan Zugelder
EVP, Chief Revenue Officer |
SELL
Open market or private sale
|
Direct | 6,793 Reduced 3.69% |
$339,650
$50.0 p/Share
|
May 12
2025 |
|
ZLAB
|
Du Ying
Chairperson & CEO |
SELL
Open market or private sale
|
Direct | 50,000 Reduced 9.44% |
$1,484,000
$29.68 p/Share
|
May 12
2025 |
|
FA
|
Bret T Jardine
Chief Legal Officer |
SELL
Open market or private sale
|
Direct | 146 Reduced 2.14% |
$2,654
$18.18 p/Share
|
May 12
2025 |
|
TOST
|
Stephen Fredette
President |
SELL
Open market or private sale
|
Direct | 104,087 Reduced 8.98% |
$4,425,779
$42.52 p/Share
|
May 12
2025 |
|
TOST
|
Stephen Fredette
President |
SELL
Open market or private sale
|
Indirect | 151,095 Reduced 0.0% |
$6,423,048
$42.51 p/Share
|
May 12
2025 |
|
RCL
|
Maritza Gomez Montiel
Director |
SELL
Open market or private sale
|
Direct | 1,500 Reduced 9.4% |
$363,735
$242.49 p/Share
|
May 12
2025 |
|
AMRX
|
John Kiely
Director |
SELL
Open market or private sale
|
Direct | 50,000 Reduced 16.26% |
$379,500
$7.59 p/Share
|
May 12
2025 |
|
LOPE
|
Lisa Graham Keegan |
SELL
Open market or private sale
|
Direct | 500 Reduced 15.76% |
$97,835
$195.67 p/Share
|
May 12
2025 |
|
SHOO
|
Al Ferrara
Director |
BUY
Open market or private purchase
|
Direct | 4,000 Added 15.21% |
$104,240
$26.06 p/Share
|
May 12
2025 |
|
RYAN
|
Anthony J Kuczinski
Director |
BUY
Open market or private purchase
|
Direct | 300 Added 13.09% |
$21,111
$70.37 p/Share
|
May 12
2025 |
|
EQH
|
Daniel G Kaye
Director |
SELL
Open market or private sale
|
Direct | 5,770 Reduced 9.94% |
$311,176
$53.93 p/Share
|
May 12
2025 |